The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, ...

GenomOncology, a precision medicine software company, and Pillar Biosciences, a leader in Decision Medicinetm, today announced a co-marketing partnership aimed at advancing precision oncology care.

From cycle tracking to better sleep insights, the latest Oura Ring is packed with features designed to support overall health ...

Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...